Biotechnology EXCLUSIVE: PainReform’s Non-Opiate Post-Surgical Pain Relief Treatment Outperforms Rival Medicine Under Various Testing Conditions – PainReform (NASDAQ:PRFX) Read more
Biotechnology Johnson & Johnson’s Carvykti Stands Ahead Of Bristol Myers’ Rival Blood Cancer Therapy With FDA Approval For Wider Population – Legend Biotech (NASDAQ:LEGN), Johnson & Johnson (NYSE:JNJ) Read more
Stockmarkets Background screening firm First Advantage to buy rival Sterling in $2.2 billion deal Reuters via biedexmarkets.com Read more
Commodities Palm oil buyers switch to cheaper rival oils, hampering price recovery Reuters via biedexmarkets.com Read more